Kenneth Sandstöm
Nessuna posizione attualmente
Profilo
Kenneth Sandstöm worked as a Principal at AKELA Pharma Oy and Leiras.
He also served as a Project Manager-Product Development at BBS-Bioactive Bone Substitutes Plc.
Precedenti posizioni note di Kenneth Sandstöm
| Società | Posizione | Fine |
|---|---|---|
AKELA Pharma Oy
 AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million. | Corporate Officer/Principal | - |
Leiras
 Leiras Pharmaceuticals: OtherHealth Technology Part of Bayer AG, Leiras is a Finnish company that specializes in medicinal chemicals and botanical products. The company is located in Finland. Leiras was acquired by Bayer Schering Pharma AG on July 01, 1996 for $262.11 million. | Corporate Officer/Principal | - |
| BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BBS-BIOACTIVE BONE SUBSTITUTES OYJ | Health Technology |
| Aziende private | 2 |
|---|---|
AKELA Pharma Oy
AKELA Pharma Oy Pharmaceuticals: OtherHealth Technology AKELA Pharma Oy, founded in 2000, develops inhalers, inhalation products, and related production technology. The company is based in Turku, Finland. AKELA Pharma was acquired by LAB International, Inc. on January 12, 2004 for $1.85 million. | Health Technology |
Leiras
Leiras Pharmaceuticals: OtherHealth Technology Part of Bayer AG, Leiras is a Finnish company that specializes in medicinal chemicals and botanical products. The company is located in Finland. Leiras was acquired by Bayer Schering Pharma AG on July 01, 1996 for $262.11 million. | Health Technology |
- Borsa valori
- Insiders
- Kenneth Sandstöm
